On June 19, 2019, the Mexican Senate ratified the agreement (114 yes, 3 no, 3 abstentions). [88] Mexico`s ratification process will be completed when the President announces its ratification to the Federal Register. The agreement between the United States of America, the United States of Mexico and Canada[1], commonly known as the United States-Mexico-Canada Agreement (USMCA), is a free trade agreement between Canada, Mexico and the United States in lieu of the North American Free Trade Agreement (NAFTA). [2] [3] [4] The agreement has been referred to as NAFTA 2.0[5][7][7] or “New ALEFTA[8][9],[9] since many nafta provisions have been introduced and its amendments have been found to be largely incremental. On 1 July 2020, the USMCA came into force in all Member States. Under the leadership of President Donald J. Trump, the United States renegotiated the North American Free Trade Agreement and replaced it with an updated and balanced agreement that works much better for North America, the U.S.-Mexico-Canada Agreement (USMCA), which came into effect on July 1, 2020. The USMCA is a mutually beneficial benefit to workers, farmers, farmers and businesses in North America. The agreement creates more balanced and reciprocal trade that supports high-paying jobs for Americans and cultivates the North American economy. On April 3, 2020, Canada informed the United States and Mexico that it had completed its national process of ratifying the agreement.

[104] The U.S.-Mexico-Canada agreement is based on the North American Free Trade Agreement (NAFTA), which originally came into force on January 1, 1994. The agreement under consideration was the result of more than a year of negotiations including possible U.S. tariffs on Canada, in addition to the possibility of separate bilateral agreements. [20] The U.S.-Mexico-Mexico-Canada Agreement (USMCA) is a trade agreement between these parties. The USMCA replaced the North American Free Trade Agreement (NAFTA). The FDA was an important member of the U.S. team that negotiated the U.S.-Mexico-Canada Agreement (USMCA), which came into effect on July 1 of this year. From the FDA`s perspective, the agreement adapts regulatory standards to public administration practices, improves the quality of products available to U.S. consumers and a level playing field for U.S. companies. Growing objections within Member States to U.S. trade policy and various aspects of the USMCA have had an impact on the signing and ratification process.

Mexico said it would not sign the USMCA if tariffs on steel and aluminum were maintained. [62] Based on the results of the November 6, 2018 U.S. election, it has been speculated that the greater power of Democrats in the House of Representatives could jeopardize the passage of the USMCA agreement. [63] [64] Bill Pascrell, a senior Democrat, argued for changes to the USMCA to pass Congress. [65] Republicans have opposed the USMCA provisions that impose labour rights on LGBTQ and pregnant workers. [66] Forty Republicans in Congress have asked Mr. Trump not to sign an agreement that includes “the unprecedented integration of sexual orientation and the language of gender identity.” As a result, Trump ultimately signed a revised version that required each nation only to “policies it deems appropriate to protect workers from discrimination in the workplace” and said the United States would not be required to introduce additional non-discrimination laws. [67] The Canadian government expressed concern about the changes that have occurred under the USMCA agreement. [68] An April 2019 Analysis by the International Trade Commission on the likely effects of the USMCA estimated that if the agreement were fully implemented (six years after ratification), the agreement would increase the United States.